Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Sanofi India Limited
SANOFI | NSE
3,190.90
INR-126.90
-3.82%
SANOFI | NSE
Loading StockChartView...
About Sanofi India Limited
Sector
Healthcare
Industry
Drug Manufacturers-General
Earnings date
30/06/2024
As of date
27/03/2026
Close
3,190.90
Open
3,317.80
High
3,335.00
Low
3,160.00
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India Singapore and internationally. It provides pharmaceutical products in various therapeutic areas such as diabetes cardiology thrombosis central nervous system anti-infective epilepsy allergy and vitamins antihistamines and minerals and supplements under the Lantus Toujeo Clexane Amaryl Cardace Targocid Frisium Combiflam DePura Allegra and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
View LessSANOFI | NSE
Risk
26.1
Sharpe
-2.32
Luna's Score
42/100
Recommendation
Sell
Luna says (SANOFI | NSE)
What's Working
Low 6-Month Volatility (<30%)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
33.9%1 month
26.1%3 months
22.1%6 months
18.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
29.45
Fwd. PE
-
Price to book
23.14
Debt to equity
0.03
Debt to assets
0.02
Ent. to EBITDA
20.28
Ent. to rev.
5.66
PEG
-
Other Fundamentals
EBITDA
7.78B
MarketCap
73.49B
MarketCap(USD)
776.58M
Div. yield
2.43
Op. margin
23.02
Erngs. growth
-16.00
Rev. growth
-34.40
Ret. on equity
75.07
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
442.70
Range1M
980.00
Range3M
1.08K
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
3.41
Price X volume
310.74M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 20.28 | 25.64 | Cheaper |
| Ent. to Revenue | 5.66 | 6.59 | Par |
| PE Ratio | 29.45 | 41.48 | Cheaper |
| Price to Book | 23.14 | 10.46 | Expensive |
| Dividend Yield | 2.43 | 0.96 | Leader |
| Std. Deviation (3M) | 22.13 | 41.14 | Lower Risk |
| Debt to Equity | 0.03 | 0.14 | Cheaper |
| Debt to Assets | 0.02 | 0.08 | Cheaper |
| Market Cap | 73.49B | 186.70B | Emerging |
